‌

US Patent 7850962 Human monoclonal antibodies against CD20

Patent 7850962 was granted and assigned to Genmab A/S on December, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jessica Teeling0

Martin Glennie0

Paul Parren0

Sigrid Ruuls0

Yvo Graus0

Arnout F. Gerritsen0

Jan van de Winkel0

Date of Patent

December 14, 2010

Patent Application Number

11578818

Date Filed

April 20, 2005

Patent Citations Received

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

0

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

0

US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3

0

US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

0

US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens

0

0

Patent Primary Examiner

Patent abstract

Isolated human monoclonal antibodies which bind to and inhibit human CD20, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7850962 Human monoclonal antibodies against CD20

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.